Residential exposure to estrogen disrupting hazardous air pollutants and breast cancer risk the California teachers study

Epidemiology

Volumn 26, Issue 3, 2015, Pages 365-373

  Liu, Ruiling ^a   Nelson, David O ^a   Hurley, Susan ^a   Hertz, Andrew ^a   Reynolds, Peggy ^a,b  

^a Cancer Prevention Institute of California   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BIPHENYL; CADMIUM DERIVATIVE; CHLOROBENZILATE; ENDOCRINE DISRUPTOR; ESTROGEN DISRUPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; AIR POLLUTANT; ANTIESTROGEN;

ADULT; AGED; AIR POLLUTANT; ARTICLE; BODY MASS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; SOCIAL STATUS; UNITED STATES; ADVERSE EFFECTS; BREAST NEOPLASMS; CHEMICALLY INDUCED; EXPOSURE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNIVERSITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AIR POLLUTANTS; BREAST NEOPLASMS; CALIFORNIA; COHORT STUDIES; ENDOCRINE DISRUPTORS; ESTROGEN ANTAGONISTS; FACULTY; FEMALE; HUMANS; INHALATION EXPOSURE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; YOUNG ADULT;

EID: 84937946693     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/eDe.0000000000000277     Document Type: Article

References (40)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available at: http://globocan.iarc.fr. Accessed August 5, 2014.
2. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2:133-140.
3. Nagata C, Nagao Y, Nakamura K, et al. Cadmium exposure and the risk of breast cancer in Japanese women. Breast Cancer Res Treat. 2013;138:235-239.
4. Julin B, Wolk A, Bergkvist L, Bottai M, Akesson A. Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study. Cancer Res. 2012;72:1459-1466.
5. Brody JG, Moysich KB, Humblet O, et al. Environmental pollutants and breast cancer: epidemiologic studies. Cancer. 2007;109:2667-2711.
6. Darbre PD, Charles AK. Environmental oestrogens and breast cancer: evidence for combined involvement of dietary, household and cosmetic xenoestrogens. Anticancer Res. 2010;30:815-827.
7. U.S. EPA. Overview: The Clean Air Act Amendments of 1990. Available at: http://epa.gov/oar/caa/caaa-overview.html. Accessed December 26, 2013.
8. U.S. EPA. National Air Toxics Assessments. Available at: http://www.epa. gov/nata/. Accessed March 4, 2013.
9. IE H. Chemicals purported to be endocrine disrupters. A compilation of published lists. (Web Report W20) Leicester, UK: MRC Institute for Environment and Health, 2005.
10. TE DX. TEDX List of Potential Endocrine Disruptors. Available at: http://endocrinedisruption.org/endocrine-disruption/tedx-list-of-potential-endocrine-disruptors/overview. Accessed October 2013.
11. U.S. EPA. Technology Transfer Network 2002 National-Scale Air Toxics Assessment. Available at: http://www.epa.gov/ttn/atw/nata2002/methods. html. Accessed August 6, 2014.
12. Garcia E, Hurley S, Nelson DO, Gunier RB, Hertz A, Reynolds P. Evaluation of the agreement between modeled and monitored ambient hazardous air pollutants in California. Int J Environ Health Res. 2014;24:363-377.
13. Crouse DL, Goldberg MS, Ross NA, Chen H, Labrèche F. Postmenopausal breast cancer is associated with exposure to traffic-related air pollution in Montreal, Canada: a case-control study. Environ Health Perspect. 2010;118:1578-1583.
14. Nie J, Beyea J, Bonner MR, et al. Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control. 2007;18:947-955.
15. Lewis-Michl EL, Melius JM, Kallenbach LR, et al. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York. Arch Environ Health. 1996;51:255-265.
16. Bonner MR, Han D, Nie J, et al. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev. 2005;14:53-60.
17. Huo Q, Zhang N, Wang X, Jiang L, Ma T, Yang Q. Effects of ambient particulate matter on human breast cancer: is xenogenesis responsible? PLoS One. 2013;8:e76609.
18. Wei Y, Davis J, Bina WF. Ambient air pollution is associated with the increased incidence of breast cancer in US. Int J Environ Health Res. 2012;22:12-21.
19. Romanowicz-Makowska H, Forma E, Bry? M, Krajewska WM, Smolarz B. Concentration of cadmium, nickel and aluminium in female breast cancer. Pol J Pathol. 2011;62:257-261.
20. Strumylaite L, Bogusevicius A, Abdrachmanovas O, et al. Cadmium concentration in biological media of breast cancer patients. Breast Cancer Res Treat. 2011;125:511-517.
21. Strumylaite L, Kregzdyte R, Bogusevicius A, Poskiene L, Baranauskiene D, Pranys D. Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: epidemiological evidence. Breast Cancer Res Treat. 2014;145:225-232.
22. Gallagher CM, Chen JJ, Kovach JS. Environmental cadmium and breast cancer risk. Aging (Albany NY). 2010;2:804-814.
23. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. Cadmium exposure and breast cancer risk. J Natl Cancer Inst. 2006;98:869-873.
24. Adams SV, Quraishi SM, Shafer MM, et al. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative. Environ Health Perspect. 2014;122:594-600.
25. Itoh H, Iwasaki M, Sawada N, et al. Dietary cadmium intake and breast cancer risk in Japanese women: a case-control study. Int J Hyg Environ Health. 2014;217:70-77.
26. Garland M, Morris JS, Colditz GA, et al. Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol. 1996;144:653-660.
27. Hinwood AL, Jolley DJ, Sim MR. Cancer incidence and high environmental arsenic concentrations in rural populations: results of an ecological study. Int J Environ Health Res. 1999;9:131-141.
28. Aballay LR, Díaz Mdel P, Francisca FM, Muñoz SE. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina. Int J Environ Health Res. 2012;22:220-231.
29. Agency for Toxic Substances & Disease Registry (AT SDR). ATSDR Toxic Substances Portal. Available at: http://www.atsdr.cdc.gov/substances/index. asp. Accessed July 6, 2014.
30. Davey JC, Bodwell JE, Gosse JA, Hamilton JW. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci. 2007;98:75-86.
31. Dyer CA. Heavy metals as endocrine-disrupting chemicals. In: Gore AC, ed. Endocrine-Disrupting Chemicals: From Basic Research to Clinical Practice. Totowa, NJ: Humana Press Inc.; 2007:111-133.
32. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrinedisrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33:378-455.
33. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558-1568.
34. Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids. 2013;78:161-170.
35. Johnson MD, Kenney N, Stoica A, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med. 2003;9:1081-1084.
36. Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol. 2000;14:545-553.
37. Stoica A, Pentecost E, Martin MB. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. Endocrinology. 2000;141:3595-3602.
38. Xu Y, Tokar EJ, Waalkes MP. Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation. Arch Toxicol. 2014;88:263-274.
39. Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin JF, Waalkes MP. Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect. 2009;117:1847-1852.
40. Straif K, Benbrahim-Tallaa L, Baan R, et al; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10:453-454.